BRPI0921791B1 - uso de um material que compreende copolímero de poli(etilenoglicol)/polidiidroxiacetona (peg-pdha) na fabricação de medicamentos - Google Patents

uso de um material que compreende copolímero de poli(etilenoglicol)/polidiidroxiacetona (peg-pdha) na fabricação de medicamentos Download PDF

Info

Publication number
BRPI0921791B1
BRPI0921791B1 BRPI0921791A BRPI0921791A BRPI0921791B1 BR PI0921791 B1 BRPI0921791 B1 BR PI0921791B1 BR PI0921791 A BRPI0921791 A BR PI0921791A BR PI0921791 A BRPI0921791 A BR PI0921791A BR PI0921791 B1 BRPI0921791 B1 BR PI0921791B1
Authority
BR
Brazil
Prior art keywords
pdha
peg
copolymer
block
ring
Prior art date
Application number
BRPI0921791A
Other languages
English (en)
Portuguese (pt)
Inventor
Putnam David
Spector Jason
Zaweneh Peter
Original Assignee
Univ Cornell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cornell filed Critical Univ Cornell
Publication of BRPI0921791A2 publication Critical patent/BRPI0921791A2/pt
Publication of BRPI0921791B1 publication Critical patent/BRPI0921791B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/42—Chemical after-treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
BRPI0921791A 2008-11-03 2009-11-03 uso de um material que compreende copolímero de poli(etilenoglicol)/polidiidroxiacetona (peg-pdha) na fabricação de medicamentos BRPI0921791B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11073408P 2008-11-03 2008-11-03
PCT/US2009/063177 WO2010062783A2 (en) 2008-11-03 2009-11-03 Polymer compositions of dihydroxyacetone and uses thereof

Publications (2)

Publication Number Publication Date
BRPI0921791A2 BRPI0921791A2 (pt) 2015-08-25
BRPI0921791B1 true BRPI0921791B1 (pt) 2018-10-30

Family

ID=42226353

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921791A BRPI0921791B1 (pt) 2008-11-03 2009-11-03 uso de um material que compreende copolímero de poli(etilenoglicol)/polidiidroxiacetona (peg-pdha) na fabricação de medicamentos

Country Status (6)

Country Link
US (2) US8916143B2 (cg-RX-API-DMAC7.html)
EP (1) EP2362788B1 (cg-RX-API-DMAC7.html)
JP (1) JP5788326B2 (cg-RX-API-DMAC7.html)
CN (2) CN104774326B (cg-RX-API-DMAC7.html)
BR (1) BRPI0921791B1 (cg-RX-API-DMAC7.html)
WO (1) WO2010062783A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5788326B2 (ja) 2008-11-03 2015-09-30 コーネル ユニバーシティー ジヒドロキシアセトンのポリマー組成物およびその使用
EP3960215B1 (en) 2009-12-15 2024-10-16 Incept, LLC Implants and biodegradable fiducial markers
US10300026B2 (en) 2015-08-24 2019-05-28 Shanxi Yabao Health Products Co., Ltd. Use of dihydroxyacetone in preparation of anti-cancer medicaments
EP3439620B1 (en) * 2016-04-07 2020-12-16 Cornell University Polymeric dha-containing biodegradable compositions and surgical barrier devices made thereof
US10590257B2 (en) 2016-09-26 2020-03-17 The Board Of Trustees Of The Leland Stanford Junior University Biomimetic, moldable, self-assembled cellulose silica-based trimeric hydrogels and their use as viscosity modifying carriers in industrial applications
US11975123B2 (en) 2018-04-02 2024-05-07 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
US11969526B2 (en) 2017-04-03 2024-04-30 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
US12599706B2 (en) 2017-04-03 2026-04-14 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
CN107141464B (zh) * 2017-05-14 2019-02-19 辽宁大学 一种通过希夫碱载药的两亲性聚碳酸酯聚乙二醇聚合物及其制备方法和应用
EP3860613B1 (en) 2018-10-01 2025-09-10 The Board of Trustees of the Leland Stanford Junior University Injectable hydrogels for controlled release of immunomodulatory compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049795A (en) * 1971-05-14 1977-09-20 Centre D'etudes Experimentales Et Cliniques De Physio Biologie De Pharmacologie Et D'eutonologie Treatment of hemorrhagic shock
EP0884045A1 (en) * 1997-06-06 1998-12-16 Pfizer Products Inc. Self-tanning dihydroxyacetone formulations having improved stability and providing enhanced delivery
US7659420B2 (en) * 2004-05-05 2010-02-09 Cornell Research Foundation, Inc Dihydroxyacetone-based polymers
US7910135B2 (en) * 2006-10-13 2011-03-22 Uluru Inc. Hydrogel wound dressing and biomaterials formed in situ and their uses
WO2008105178A1 (ja) * 2007-02-28 2008-09-04 National University Corporation Hokkaido University リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム
JP5788326B2 (ja) 2008-11-03 2015-09-30 コーネル ユニバーシティー ジヒドロキシアセトンのポリマー組成物およびその使用

Also Published As

Publication number Publication date
US8916143B2 (en) 2014-12-23
EP2362788A2 (en) 2011-09-07
US20110212049A1 (en) 2011-09-01
CN102264399A (zh) 2011-11-30
CN104774326A (zh) 2015-07-15
CN104774326B (zh) 2017-04-12
EP2362788B1 (en) 2016-06-01
EP2362788A4 (en) 2013-04-03
JP2012508173A (ja) 2012-04-05
WO2010062783A3 (en) 2010-07-22
WO2010062783A2 (en) 2010-06-03
CN102264399B (zh) 2015-03-25
US20150079019A1 (en) 2015-03-19
US9629870B2 (en) 2017-04-25
JP5788326B2 (ja) 2015-09-30
BRPI0921791A2 (pt) 2015-08-25

Similar Documents

Publication Publication Date Title
CN104774326B (zh) 二羟基丙酮的聚合物组合物和其用途
Yang et al. Injectable adaptive self-healing hyaluronic acid/poly (γ-glutamic acid) hydrogel for cutaneous wound healing
Li et al. Antibacterial, hemostasis, adhesive, self-healing polysaccharides-based composite hydrogel wound dressing for the prevention and treatment of postoperative adhesion
Shi et al. Supramolecular chitin-based hydrogels with self-adapting and fast-degradation properties for enhancing wound healing
Zhang et al. A self-healing hydrogel wound dressing based on oxidized Bletilla striata polysaccharide and cationic gelatin for skin trauma treatment
CN102196805B (zh) 透明质酸或其盐之一、多元醇和利多卡因的热灭菌的注射型组合物
JP6720279B2 (ja) 変性コラーゲン
KR101845885B1 (ko) 입자형 무세포 진피 기반의 온도감응성 유착방지 조성물의 제조방법
PT2470230E (pt) Geles viscoelásticos como enchimentos inovadores
US20130252921A1 (en) Adhesion barrier containing hyaluronic acids and l-arginine
AU2003221916A1 (en) Tissue defect dressings comprising a keratin network
CN109627463A (zh) 水凝胶与蛋白质药物
KR20150128481A (ko) 세포외기질 및 온도감응성 고분자를 포함하는 생체 피부용 조성물
EP3934659A1 (en) System and method to reduce tissue or organ adhesion
US20040062793A1 (en) Tissue defect dressings comprising proteinaceous networks
CN103159967A (zh) 一种具有自抗炎功能的胶原基海绵伤口敷料的制备方法
KR101637883B1 (ko) 폴리에틸렌글리콜 수화젤 주사제
CN114514267A (zh) 包含透明质酸和聚乙二醇的生物相容性水凝胶
JP6916353B1 (ja) 癒着防止用高分子組成物
Prabhakar et al. Bioengineering of chitosan/citric acid/curcumin nanofiber scaffolds for treatment of spinal cord injury
CN116003830A (zh) 超吸收性水凝胶及其制备方法和应用
CN120114380A (zh) 一种递送外泌体的紫外响应型水凝胶及其制备方法和应用
KR101000537B1 (ko) 콜라겐 패치 베이스 및 이의 제조방법
Zhang et al. Sprayable Dual‐Network Microgel Adhesive for Robust Wet Adhesion and Prolonged Analgesia in Complex Wounds
Junior et al. Rheological characterization of genipin-based crosslinking pigment and O-Carboxymethyl Chitosan–oxidized hyaluronic acid in situ formulable hydrogels

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09A Decision: intention to grant
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/11/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 10A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2538 DE 27-08-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.